TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.'s KVA12123 Novel anti-VISTA Checkpoint Inhibitor
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://d1io3yog0oux5.cloudfront.net/_ea41b6671ddf1a0affe04c0340352773/kintara/news/2024-07-08_TuHURA_Biosciences_Enters_into_Exclusivity_and_1043.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (1)
Alternatively, you can try searching for similar contracts: